Dr. Gottlieb resigned from the FDA in April after running the agency for two years. Throughout his tenure he became known for cracking down on the e-cigarette industry and trying to get a handle on the opioid crisis.
Dr. Gottlieb will serve on two committees on Pfizer’s board, regulatory and compliance and science and technology.
“I’m honored to be joining the board of directors of #Pfizer and working together with more than 90,000 Pfizer colleagues to promote medical innovation, advance patient care, and secure access to better healthcare outcomes for families around the world,” Dr. Gottlieb tweeted June 27.
More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva’s $85M opioid settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
